Technology | April 08, 2010

New SBRT Solution Leverages 4-D to Track Lung Tumors

April 8, 2010 - Lung tumors have been among the most challenging radiation therapy targets because the patient's breathing causes tumors to move.

While external skin surface markers or implanted markers are used to estimate lung tumor position during the breathing cycle, the physician can only apply the beam during certain points in the patient's respiration. These strategies require complex, time-consuming planning and delivery, and prolong treatment with an inefficient stop-start beam delivery.

Elekta has introduced technology for stereotactic body radiation therapy (SBRT) for treating lung tumors. The solution is designed to enable doctors to use 4-D image guidance to confirm the tumor's location during the breathing cycle. This new technology treats the lesion with a continuous radiation beam, increasing therapy accuracy while using less imaging radiation during treatment delivery.

Elekta's XVI Symmetry provides tools to manage shifts in the relative positions of the tumor and organs-at-risk during the respiratory cycle. XVI Intuity is applied to ensure the position of the tumor is being tracked, and it accounts for the position of nearby healthy critical structures.

XVI Symmetry and XVI Intuity are feature sets of version 4.5 of Elekta's X-ray Volume Imaging (XVI) package of software solutions for Image Guided Radiation Therapy (IGRT). XVI 4.5 recently received 510(k) clearance and CE marking, to enable sales and distribution in the United States and Europe.

The solutions account for baseline shifts and help physicians deliver treatment using reduced margins around the tumor.

XVI Intuity is designed to extend image guidance by enabling critical structure avoidance, which allows doctors to understand the positional relationship between the target and organs-at-risk. This provides for anatomical changes and corrections to set-up errors have not inadvertently put critical structures into the radiation beam's path.

For more information:

Related Content

News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
News | Image Guided Radiation Therapy (IGRT) | July 13, 2017
Elekta and Sunnybrook Health Sciences Centre have initiated installation of Elekta’s MR-linac, an investigational...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the...
Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system

Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system. Combined, these systems will allow for simultaneous radiation therapy delivery and high-field MR tumor monitoring.

Feature | Radiation Oncology | July 05, 2017 | By Jeff Zagoudis
Image-guided radiation therapy offers great potential to improve the efficiency of treating cancer patients by more...

Photo courtesy of RaySearch

Feature | Treatment Planning | July 05, 2017 | By Jeff Zagoudis
While radiation oncologists have a number of proven techniques at their disposal for treating patients, the reality is...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of...
Overlay Init